Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 16, 2025 03:05 ET | Source: TVM Life Science Management GmbH

TVM Capital Life Science Portfolio Company Smart Reporting to Acquire Fluency for Imaging - Uniting to Create Jacobian™ and Accelerate AI-Powered Reporting

MUNICH, Germany and MONTREAL, Oct. 16, 2025 (GLOBE NEWSWIRE) -- TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on investments in life sciences innovation,...
April 22, 2024 02:00 ET | Source: TVM Life Science Management GmbH

TVM Capital Life Science Leads €23 Million Series C Financing Round for Medical Reporting Technology Pioneer, Smart Reporting

MUNICH, Germany and MONTREAL, April 22, 2024 (GLOBE NEWSWIRE) -- TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on investments in life sciences innovation,...
March 13, 2024 10:00 ET | Source: TVM Life Science Management GmbH

TVM Capital Life Science to Participate in LSI USA ’24 Emerging Medtech Summit 2024

TVM CAPITAL LIFE SCIENCE TO PARTICIPATE IN LSI USA ’24 EMERGING MEDTECH SUMMIT 2024
February 06, 2024 04:07 ET | Source: TVM Life Science Management GmbH

TVM Capital Life Science Co-Leads $16 Million Series A Financing Round for Vektor Medical to Revolutionize Arrhythmia Care

MUNICH, Germany and MONTREAL, Feb. 06, 2024 (GLOBE NEWSWIRE) -- TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on investments in life sciences innovation,...
January 31, 2024 04:00 ET | Source: TVM Life Science Management GmbH

TVM Capital Life Science Announces €8 Million Investment in myo to Revolutionize Elderly Care via Innovative, Easy-to-Use App

MUNICH, Germany and MONTREAL, Jan. 31, 2024 (GLOBE NEWSWIRE) -- TVM Capital Life Science (“TVM”), a leading transatlantic venture capital firm focused on investments in life sciences innovation,...
July 20, 2023 08:00 ET | Source: TVM Life Science Management GmbH

Tillotts Pharma and TVM Capital Life Science Announce Formation of Mage Biologics to Develop Innovative Oral Antibody Therapy for Ulcerative Colitis

Mage Biologics to develop a monoclonal antibody targeting ulcerative colitis Novel antibody specifically designed for oral administration utilizes Tillotts Pharma’s sustained release approach to...
March 17, 2023 09:00 ET | Source: TVM Life Science Management GmbH

TVM Capital Life Science to participate in LSI USA ’23 Emerging Medtech Summit 2023

MONTREAL and MUNICH, Germany, March 17, 2023 (GLOBE NEWSWIRE) -- TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on investments in life sciences innovation,...
February 23, 2023 08:00 ET | Source: TVM Life Science Management GmbH

TVM Capital Life Science Announces Promotions to Recognize Significant Contributions of Up-and-Coming Leaders

MONTREAL, Canada and MUNICH, Germany, Feb. 23, 2023 (GLOBE NEWSWIRE) -- TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on investments in life sciences...
February 08, 2023 08:00 ET | Source: TVM Life Science Management GmbH

TVM Capital Life Science Announces Creation of LAmAb Biologics to Develop Innovative Preventative Therapy for Allergy Patients

LAmAb Biologics to develop first-in-class monoclonal antibody prophylactic therapeutic targeting IgE, a key mediator for allergic diseases LAmAb Biologics is the 9th early-stage or product focused...
February 01, 2023 08:00 ET | Source: TVM Life Science Management GmbH

TVM Capital Life Science announces up to USD 24 million investment in oncology company, Recurv Pharma, Inc.

Recurv is the 8th early-stage or product focused company (PFC) investment for TVM Life Science Innovation II Fund Recurv is developing novel taxane, RP-001, against solid tumors RP-001 delivered in...